Cargando…

Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity

In this retrospective cohort study, we investigated the formation of individual classes of antibodies to SARS-CoV-2 in archived serial sera from hospitalized patients with the medium–severe (n = 17) and severe COVID-19 (n = 11). The serum/plasma samples were studied for the presence of IgG, IgM and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desheva, Yulia, Lerner, Anna, Shvedova, Tamara, Kopteva, Olga, Kudar, Polina, Koroleva, Irina, Leontieva, Galina, Suvorov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045262/ https://www.ncbi.nlm.nih.gov/pubmed/36975366 http://dx.doi.org/10.3390/antib12010019

Ejemplares similares

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021)

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019)

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
por: Desheva, Yulia, et al.
Publicado: (2022)

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
por: Roper, Kelly J., et al.
Publicado: (2023)

A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology
por: Shilova, Olga, et al.
Publicado: (2021)

Study of Antibody-Dependent Reactions of Mast Cells In Vitro and in a Model of Severe Influenza Infection in Mice
por: Mamontov, Andrey, et al.
Publicado: (2021)

Autoprobiotics as an Approach for Restoration of Personalised Microbiota
por: Suvorov, Alexander, et al.
Publicado: (2018)

Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
por: Desheva, Yulia, et al.
Publicado: (2023)

DETECTION OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODIES IN HUMAN SERA
por: Karakawa, Walter W., et al.
Publicado: (1965)

AN ELECTROPHORETIC STUDY OF IMMUNE SERA AND PURIFIED ANTIBODY PREPARATIONS
por: Tiselius, Arne, et al.
Publicado: (1939)

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
por: Desheva, Yulia A, et al.
Publicado: (2015)

IgG Study of Blood Sera of Patients with COVID-19
por: Kazachinskaia, Elena, et al.
Publicado: (2021)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

ANTIBODIES TO POLYNUCLEOTIDES IN HUMAN SERA: ANTIGENIC SPECIFICITY AND RELATION TO DISEASE
por: Koffler, D., et al.
Publicado: (1971)

Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001)

Design of epitope-specific probes for sera analysis and antibody isolation
por: Georgiev, I, et al.
Publicado: (2012)

Toxoplasma gondii Antibodies in Raw Milk and Sera of Cows in China
por: Liu, Yu-Min, et al.
Publicado: (2022)

¿Será Real?.
Publicado: (2008)

Immune Sera
Publicado: (1919)

The Standardisation of Sera
Publicado: (1921)

Development of experimental GBS vaccine for mucosal immunization
por: Gupalova, T., et al.
Publicado: (2018)

THE DETERMINATION OF ANTIBODY TO GROUP A STREPTOCOCCAL POLYSACCHARIDE IN HUMAN SERA BY HEMAGGLUTINATION
por: Schmidt, Willard C., et al.
Publicado: (1965)

ANTIPROTEINS IN HORSE SERA : II. ANTIBODIES TO PNEUMOCOCCUS NUCLEOPROTEIN AND THEIR REACTION WITH ANTIGEN
por: Heidelberger, Michael
Publicado: (1947)

THE LOCALIZATION OF SKIN-SENSITIZING ANTIBODY IN THE SERA OF RAGWEED-SENSITIVE INDIVIDUALS BY ELECTROPHORESIS
por: Sehon, Alec H., et al.
Publicado: (1956)

THE PRECIPITIN REACTION OF ANTIPNEUMOCOCCUS SERA : II. THE RATIO OF PRECIPITIN TO PROTECTIVE ANTIBODY
por: Friedlander, Mae, et al.
Publicado: (1928)

Cannot write session to /tmp/vufind_sessions/sess_32d455dlum4l57jsuaabdskefc